Does age matter in MAT?
When someone starts a medication-assisted treatment (MAT) program, many factors come into play: the substance involved, the duration of use, co-occurring conditions, and overall health. But it’s important not to overlook one crucial factor: Age. Age and MAT are deeply connected, as the age of the person seeking treatment can significantly affect how the process unfolds.
So, if you are asking yourself, “Does age matter in MAT?” The answer is yes. Age plays a critical role not only in how the body reacts to medications but also in how individuals experience recovery. Understanding these differences helps create a more personalized approach, setting the stage for a successful treatment journey.
Let’s understand in this blog by MAT Care Clinics the importance of age to tailor the right approach to ensure the best chance for success at any stage of life for individuals dealing with substance dependence.
Opioid Substance Use Statistics by Age Group
Before we delve into the precise correlation between age and MAT, it’s essential to examine the variations in opioid substance use across different age groups. According to SAMHSA, opioid misuse remains a significant concern. In 2021, about 3.3% of people aged 12 or older, equating to 9.2 million individuals, misused opioids. The lowest rates of misuse were among adolescents aged 12 to 17, at 1.9%. Young adults aged 18 to 25 and adults aged 26 and older had similar misuse rates of 3.1% and 3.5%, respectively.
Moreover, recent data from the National Center for Health Statistics shows that the rate of drug overdose deaths has dramatically increased over the past two decades, rising from 8.2 deaths per 100,000 people in 2002 to 32.6 in 2022. While the overall rate remained stable from 2021 to 2022, there were notable differences among age groups.
For younger adults aged 15–24 and those aged 25–34, overdose death rates actually decreased during this time. In contrast, adults aged 35 and older experienced an increase in overdose deaths, with the highest rates observed in those aged 35–44. Among older adults aged 65 and above, the rate also rose, marking a 10% increase from 12.0 to 13.2 deaths per 100,000.
Age and MAT: Why Age Matter?
Age affects nearly every aspect of how our bodies and minds respond to addiction and recovery. Young adults face unique challenges in their treatment for opioid use disorder, and the Journal of Adolescent Health highlights the higher relapse rates in this group compared to older adults. In a trial comparing the effectiveness of extended-release naltrexone (XR-NTX) and sublingual buprenorphine-naloxone, young adults aged 18–25 had a 70.3% relapse rate, significantly higher than the 58.2% seen in adults over 26.
These findings suggest that younger individuals are more vulnerable to dropping out of treatment or not adhering to medication, making importance the development of treatment plans that take into account the specific life stages and challenges of young adults, such as balancing school, work, and social pressures.
On the other hand, middle-aged adults often face the challenge of juggling multiple responsibilities, such as maintaining careers and raising children. These demands can create high levels of stress, which may interfere with adherence to a MAT program. For this age group, the struggle isn’t always about health complications but about finding the time and mental bandwidth to prioritize recovery amidst their many obligations. In some cases, stress-related conditions like anxiety or insomnia may arise, necessitating additional mental health support to improve treatment outcomes.
For older adults, MAT involves additional complexities due to age-related changes in their bodies and health conditions. As metabolism slows down, medications like opioids may be absorbed and eliminated differently, requiring tailored dosages and close monitoring. Older adults often deal with multiple health issues, such as heart disease or cognitive decline, and are usually on several medications, increasing the likelihood of dangerous drug interactions.
Furthermore, according to Drugs and Aging, MAT options like methadone may pose added risks, such as respiratory depression and heart complications, which is why medications like buprenorphine, with a safer profile, are often preferred. Social factors, including isolation or a lack of mobility, can also make consistent treatment access challenging, further complicating their treatment journey.
Addressing Misconceptions: “Isn’t MAT Only for Certain Age Groups?”
One misconception is that MAT is only appropriate for middle-aged adults or those with long-term substance use. In reality, MAT can be beneficial for people of all ages who are dealing with opioid use disorder (OUD) or other substance addictions.
For younger people, early intervention through MAT can prevent years of struggle. For older adults, MAT can offer a safer, more controlled way to reduce dependency, even if they’ve been using substances for decades. In both cases, the treatment can help manage withdrawal symptoms, reduce cravings, and create a more stable foundation for long-term recovery.
Finding the Right Support with MAT Care Clinics
The key to success with MAT is finding the right fit based on the individual’s age, medical history, and unique needs. This process involves close coordination with healthcare providers to develop a treatment plan that addresses all aspects of the person’s health—mental, physical, and emotional.
No matter the age, the goal of MAT remains the same: to offer a path to recovery that balances medication support with behavioral therapies so individuals can rebuild their lives free from addiction.
At MAT Care Clinics, we recognize the unique challenges faced by individuals of different ages in their recovery journey. We support the idea that age-related factors affect treatment and create personalized plans based on the individual. If you or a loved one are exploring MAT options, reach out to us at (833) 622-0628 or schedule a free consultation to learn how we can assist you or your loved one in achieving a successful recovery.
